| Target Price | $47.94 |
| Price | $39.10 |
| Potential | 22.61% |
| Number of Estimates | 12 |
| 12 Analysts have issued a price target Copart, Inc. 2026 . The average Copart, Inc. target price is $47.94. This is 22.61% higher than the current stock price. The highest price target is $68.25 74.55% , the lowest is $33.33 14.76% . | |
| A rating was issued by 19 analysts: 12 Analysts recommend Copart, Inc. to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Copart, Inc. stock has an average upside potential 2026 of 22.61% . Most analysts recommend the Copart, Inc. stock at Purchase. |
15 Analysts have issued a sales forecast Copart, Inc. 2026 . The average Copart, Inc. sales estimate is $4.9b . This is 4.36% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.4b 15.72% , the lowest is $4.5b 2.54% .
This results in the following potential growth metrics:
| 2025 | $4.6b | 9.68% |
|---|---|---|
| 2026 | $4.9b | 4.54% |
| 2027 | $5.2b | 6.34% |
| 2028 | $5.6b | 8.01% |
| 2029 | $6.5b | 16.13% |
| 2030 | $6.8b | 4.86% |
| 2031 | $7.5b | 9.85% |
| 2032 | $8.2b | 10.18% |
12 Analysts have issued an Copart, Inc. EBITDA forecast 2026. The average Copart, Inc. EBITDA estimate is $2.1b . This is 17.61% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.3b 31.87% , the lowest is $1.9b 7.70% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $1.7b | 8.15% |
|---|---|---|
| 2026 | $2.1b | 19.31% |
| 2027 | $2.2b | 8.82% |
| 2028 | $2.3b | 5.06% |
| 2029 | $2.7b | 13.46% |
| 2030 | $2.8b | 5.86% |
| 2025 | 37.03% | 1.40% |
|---|---|---|
| 2026 | 42.26% | 14.12% |
| 2027 | 43.24% | 2.32% |
| 2028 | 42.06% | 2.73% |
| 2029 | 41.10% | 2.28% |
| 2030 | 41.49% | 0.95% |
15 Copart, Inc. Analysts have issued a net profit forecast 2026. The average Copart, Inc. net profit estimate is $1.6b . This is 2.85% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.8b 14.44% , the lowest is $1.5b 5.98% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $1.6b | 13.90% |
|---|---|---|
| 2026 | $1.6b | 5.61% |
| 2027 | $1.8b | 8.58% |
| 2028 | $1.9b | 4.12% |
| 2029 | $2.1b | 11.85% |
| 2030 | $2.2b | 5.24% |
| 2025 | 33.41% | 3.85% |
|---|---|---|
| 2026 | 33.75% | 1.02% |
| 2027 | 34.46% | 2.10% |
| 2028 | 33.22% | 3.60% |
| 2029 | 31.99% | 3.70% |
| 2030 | 32.11% | 0.38% |
15 Analysts have issued a Copart, Inc. forecast for earnings per share. The average Copart, Inc. EPS is $1.69 . This is 3.05% higher than earnings per share in the financial year 2025. The highest EPS forecast is $1.88 14.63% , the lowest is $1.55 5.49% .
This results in the following potential growth metrics and future valuations:
| 2025 | $1.59 | 13.57% |
|---|---|---|
| 2026 | $1.69 | 6.29% |
| 2027 | $1.84 | 8.88% |
| 2028 | $1.92 | 4.35% |
| 2029 | $2.14 | 11.46% |
| 2030 | $2.25 | 5.14% |
| Current | 23.84 | 41.85% |
|---|---|---|
| 2026 | 23.08 | 3.19% |
| 2027 | 21.26 | 7.89% |
| 2028 | 20.42 | 3.95% |
| 2029 | 18.25 | 10.63% |
| 2030 | 17.35 | 4.93% |
Based on analysts' sales estimates for 2026, the Copart, Inc. stock is valued at an EV/Sales of 6.71 and an P/S ratio of 7.79 .
This results in the following potential growth metrics and future valuations:
| Current | 7.00 | 41.72% |
|---|---|---|
| 2026 | 6.71 | 4.12% |
| 2027 | 6.31 | 5.96% |
| 2028 | 5.84 | 7.42% |
| 2029 | 5.03 | 13.89% |
| 2030 | 4.80 | 4.64% |
| 2031 | 4.37 | 8.96% |
| 2032 | 3.96 | 9.24% |
| Current | 8.13 | 36.76% |
|---|---|---|
| 2026 | 7.79 | 4.18% |
| 2027 | 7.33 | 5.96% |
| 2028 | 6.78 | 7.42% |
| 2029 | 5.84 | 13.89% |
| 2030 | 5.57 | 4.64% |
| 2031 | 5.07 | 8.96% |
| 2032 | 4.60 | 9.24% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Nov 24 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Nov 21 2025 |
| Barclays |
Underweight
➜
Underweight
|
Unchanged | Nov 21 2025 |
| Barclays |
➜
Underweight
|
Initiated | Nov 12 2025 |
| Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 05 2025 |
| HSBC |
Hold
➜
Buy
|
Upgrade | Sep 04 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Jul 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Nov 24 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Nov 21 2025 |
|
Unchanged
Barclays:
Underweight
➜
Underweight
|
Nov 21 2025 |
|
Initiated
Barclays:
➜
Underweight
|
Nov 12 2025 |
|
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
Sep 05 2025 |
|
Upgrade
HSBC:
Hold
➜
Buy
|
Sep 04 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Jul 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


